Due to a shortage in Canada, Pfizer Canada ULC has informed Health Canada that a steady supply of its ZINECARD (Dexrazoxane for Injection) is not expected until January 31, 2021. Given the medical necessity of this product, Health Canada has expressed no objection to the temporary importation and distribution of US-labelled Dexrazoxane for Injection.
RecallTracker